<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34308300</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-5370</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>EClinicalMedicine</Title><ISOAbbreviation>EClinicalMedicine</ISOAbbreviation></Journal><ArticleTitle>Characterizing long COVID in an international cohort: 7 months of symptoms and their impact.</ArticleTitle><Pagination><StartPage>101019</StartPage><MedlinePgn>101019</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101019</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.eclinm.2021.101019</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A significant number of patients with COVID-19 experience prolonged symptoms, known as Long COVID. Few systematic studies have investigated this population, particularly in outpatient settings. Hence, relatively little is known about symptom makeup and severity, expected clinical course, impact on daily functioning, and return to baseline health.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted an online survey of people with suspected and confirmed COVID-19, distributed via COVID-19 support groups (e.g. Body Politic, Long COVID Support Group, Long Haul COVID Fighters) and social media (e.g. Twitter, Facebook). Data were collected from September 6, 2020 to November 25, 2020. We analyzed responses from 3762 participants with confirmed (diagnostic/antibody positive; 1020) or suspected (diagnostic/antibody negative or untested; 2742) COVID-19, from 56 countries, with illness lasting over 28 days and onset prior to June 2020. We estimated the prevalence of 203 symptoms in 10 organ systems and traced 66 symptoms over seven months. We measured the impact on life, work, and return to baseline health.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">For the majority of respondents (&gt;91%), the time to recovery exceeded 35 weeks. During their illness, participants experienced an average of 55.9+/- 25.5 (mean+/-STD) symptoms, across an average of 9.1 organ systems. The most frequent symptoms after month 6 were fatigue, post-exertional malaise, and cognitive dysfunction. Symptoms varied in their prevalence over time, and we identified three symptom clusters, each with a characteristic temporal profile. 85.9% of participants (95% CI, 84.8% to 87.0%) experienced relapses, primarily triggered by exercise, physical or mental activity, and stress. 86.7% (85.6% to 92.5%) of unrecovered respondents were experiencing fatigue at the time of survey, compared to 44.7% (38.5% to 50.5%) of recovered respondents. 1700 respondents (45.2%) required a reduced work schedule compared to pre-illness, and an additional 839 (22.3%) were not working at the time of survey due to illness. Cognitive dysfunction or memory issues were common across all age groups (~88%). Except for loss of smell and taste, the prevalence and trajectory of all symptoms were similar between groups with confirmed and suspected COVID-19.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">All authors contributed to this work in a voluntary capacity. The cost of survey hosting (on Qualtrics) and publication fee was covered by AA's research grant (Wellcome Trust/Gatsby Charity via Sainsbury Wellcome center, UCL).</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Hannah E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assaf</LastName><ForeName>Gina S</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCorkell</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Low</LastName><ForeName>Ryan J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sainsbury Wellcome Centre, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Re'em</LastName><ForeName>Yochai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, NewYork-Presbyterian Hospital / Weill Cornell Medicine, NYC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redfield</LastName><ForeName>Signe</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Austin</LastName><ForeName>Jared P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oregon Health and Science University, Portland, OR, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akrami</LastName><ForeName>Athena</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Patient-Led Research Collaborative.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sainsbury Wellcome Centre, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>EClinicalMedicine</MedlineTA><NlmUniqueID>101733727</NlmUniqueID><ISSNLinking>2589-5370</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID recovery</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 symptoms</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Long Hauler</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">Patient-Led research</Keyword><Keyword MajorTopicYN="N">Post Acute COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 Syndrome</Keyword><Keyword MajorTopicYN="N">Post-acute Sequelae of COVID-19</Keyword></KeywordList><CoiStatement>All authors have completed the ICMJE uniform disclosure form and declare: no support from any organization for the submitted work. All authors except HED and GSA declare no financial relationships with any organization that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work. HED reports personal fees ($500 speaking fee) from Council for Medical Specialty Society, outside the submitted work. GSA reports personal fees ($1000 speaking fee) from Council for Medical Specialty Society and Karolinska Institute, outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34308300</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pii">S2589-5370(21)00299-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alwan N.A. Surveillance is underestimating the burden of the COVID-19 pandemic. The Lancet. 2020 Sep;396(10252):e24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836224</ArticleId><ArticleId IdType="pubmed">32861312</ArticleId></ArticleIdList></Reference><Reference><Citation>2020. The prevalence of long COVID symptoms and COVID-19 complications [Internet]. Office for national statistics.https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications [cited 2020 Dec 17]. Available from:</Citation></Reference><Reference><Citation>Petersen M.S., Kristiansen M.F., Hanusson K.D., Danielsen M.E., &#xe1;Steig B., Gaini S. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clinical Infect Dis [Internet] 2020 doi: 10.1093/cid/ciaa1792. Nov 30 [cited 2020 Dec 17];(ciaa1792). Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A., Morley A., Viner J., Attwood M. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up; results from a prospective UK cohort. medRxiv. 2020 Aug 14;2020.08.12.20173526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli Against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. Aug 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitrani R.D., Dabas N., Goldberger J.J. COVID-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm. 2020;17(11):1984&#x2013;1990. Nov 1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7319645</ArticleId><ArticleId IdType="pubmed">32599178</ArticleId></ArticleIdList></Reference><Reference><Citation>Assaf G., Davis H., McCorkell L., Wei H., Brooke O., Akrami A.  An analysis of the prolonged COVID-19 symptoms survey by patient-led research team [Internet] 2020. What does COVID-19 recovery actually look like?https://patientresearchcovid19.com/research/report-1/ Available from:</Citation></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens D., Hastie C. 2020. Characterising long-term covid-19: a rapid living systematic review. medRxiv. Dec 9;2020.12.08.20246025.</Citation></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequalae of COVID-19. Nature. 2021:1&#x2013;8. Apr 22.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F., Perego E. How and why patients made Long Covid. Soc Sci Med. 2020 Oct 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morbid. Mortal. Weekly Report. 2020;69(30):993&#x2013;998. Jul.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE; 2020. Overview | COVID-19 rapid guideline: managing the long-term effects of COVID-19 | guidance | nice [Internet]https://www.nice.org.uk/guidance/NG188 [citedDec 19]. Available from:</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Healthcare Workers [Internet]   2020. Centers for disease control and prevention.https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html [cited 2021 May 17]. Available from:</Citation></Reference><Reference><Citation>McCorkell L., S. Assaf G., E. Davis H., Wei H., Akrami A. Patient-Led Research Collaborative: embedding patients in the Long COVID narrative. PAIN Reports. 2021;6(1):e913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112577</ArticleId><ArticleId IdType="pubmed">33987484</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A'Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020 Aug;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E., Rushforth A., Wieringa S., Taylor S., Rayner C., Husain L. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Serv Res. 2020 Dec;20(1):1144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahid A., Wilkinson K., Marcu S., Shapiro C.M.  STOP, that and one hundred other sleep scales [Internet] Springer New York; New York, NY: 2011. Fatigue assessment scale (FAS)http://link.springer.com/10.1007/978-1-4419-9893-4_33 In: Shahid A, Wilkinson K, Marcu S, Shapiro CM, editors. [cited 2020 Dec 19]. p. 161&#x2013;2. Available from:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4419-9893-4_33</ArticleId></ArticleIdList></Reference><Reference><Citation>Vries J de, Michielsen H., Heck G.L.V., Drent M. Measuring fatigue in sarcoidosis: the fatigue assessment scale (FAS) Br J Health Psychol. 2004;9(3):279&#x2013;291.</Citation><ArticleIdList><ArticleId IdType="pubmed">15296678</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinbaum D.G., Klein M.  3rd Ed. Springer-Verlag; New York: 2012. Survival analysis: a self-learning text, third edition [Internet]https://www.springer.com/gp/book/9781441966452 [cited 2020 Dec 16]. (Statistics for Biology and Health). Available from:</Citation></Reference><Reference><Citation>Dhillon I.S., Modha D.S. Concept decompositions for large sparse text data using clustering.:31.</Citation></Reference><Reference><Citation>Efron B. Better bootstrap confidence intervals. J Am Stat Assoc. 1987;82(397):171&#x2013;185.</Citation></Reference><Reference><Citation>Agarwal A.K., Garg R., Ritch A., Sarkar P. Postural orthostatic tachycardia syndrome. Postgrad Med J. 2007 Jul;83(981):478&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2600095</ArticleId><ArticleId IdType="pubmed">17621618</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon-Ceron D., Slama D., Broucker T.D., Karmochkine M., Pavie J., Sorbets E. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infection [Internet] 2020 https://www.journalofinfection.com/article/S0163-4453(20)30762-3/abstract Dec 4 [cited 2020 Dec 17];0(0). Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Stussman B., Williams A., Snow J., Gavin A., Scott R., Nath A. Characterization of post&#x2013;exertional malaise in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol [Internet] 2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530890/ Sep 18 [cited 2020 Dec 17];11. Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530890</ArticleId><ArticleId IdType="pubmed">33071931</ArticleId></ArticleIdList></Reference><Reference><Citation>Corden A., Sainsbury R. University of York; York: 2006. University of York, social policy research unit. Using verbatim quotations in reporting qualitative social research: researchers&#x2019; views.</Citation></Reference><Reference><Citation>Bird S., Loper E., Klein E. O'Reilly Media Inc; 2009. Natural language processing with Python.</Citation></Reference><Reference><Citation>Braun V., Clarke V. 2006 Dec. Using thematic analysis in psychology. Qualitative research in psychology [Internet] [cited 2020 Dec 23];3(2). Available from: https://uwe-repository.worktribe.com/output/1043060.</Citation></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C. 2020. Attributes and predictors of long-COVID: analysis of COVID cases and their symptoms collected by the COVID symptoms study app. medRxiv. Oct 21;2020.10.19.20214494.</Citation></Reference><Reference><Citation>CDC. Coronavirus Disease . 2019. (COVID-19) &#x2013; symptoms [Internet]. centers for disease control and prevention. 2020 [cited 2020 Dec 24]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.</Citation></Reference><Reference><Citation>Symptoms of coronavirus (COVID-19) [Internet]. nhs.uk. 2020 [cited 2020 Dec 24]. Available from: https://www.nhs.uk/conditions/coronavirus-covid-19/symptoms/</Citation></Reference><Reference><Citation>Afrin L.B., Weinstock L.B., Molderings G.J. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. Int J Infect Dis. 2020;100:327&#x2013;332. Nov.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH workshop on post-acute sequelae of COVID-19 (Day 2) [Internet]. Available from: https://videocast.nih.gov/watch=38879</Citation></Reference><Reference><Citation>Anjum I., Sohail W., Hatipoglu B., Wilson R.  Cureus [Internet]; 2020. Postural orthostatic tachycardia syndrome and its unusual presenting complaints in women: a literature minireview.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5988200/ [citedDec 18];10(4). Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5988200</ArticleId><ArticleId IdType="pubmed">29876157</ArticleId></ArticleIdList></Reference><Reference><Citation>IOM 2015 Diagnostic Criteria | Diagnosis | Healthcare Providers | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC [Internet]. 2019 [cited 2020 Dec 18]. Available from: https://www.cdc.gov/me-cfs/healthcare-providers/diagnosis/iom-2015-diagnostic-criteria.html</Citation></Reference><Reference><Citation>Ding H., Yin S., Cheng Y., Cai Y., Huang W., Deng W. Neurologic manifestations of nonhospitalized patients with COVID-19 in Wuhan, China. Med Comm. 2020;1(2):253&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362024</ArticleId><ArticleId IdType="pubmed">34172986</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuey K.M., Jovic E. Disability accommodation in nonstandard and precarious employment arrangements. Work Occup. 2013 May;40(2):174&#x2013;205.</Citation></Reference><Reference><Citation>Tabacof L., Tosto-Mancuso J., Wood J., Cortes M., Kontorovich A., McCarthy D. 2020. Post-acute COVID-19 syndrome negatively impacts health and wellbeing despite less severe acute infection. medRxiv. Nov 6;2020.11.04.20226126.</Citation></Reference><Reference><Citation>Liu X., Feng J., Zhang Q., Guo D., Zhang L., Suo T. Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets. Emerg Microbes Infect. 2020 Jan;9(1):1175&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448863</ArticleId><ArticleId IdType="pubmed">32448084</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson J., Whiting P.F., Brush J.E. Interpreting a covid-19 test result. BMJ. 2020 May;369:m1808.</Citation><ArticleIdList><ArticleId IdType="pubmed">32398230</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucirka L.M., Lauer S.A., Laeyendecker O., Boon D., Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction&#x2013;based SARS-CoV-2 tests by time since exposure. Ann Intern Med [Internet] 2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240870/ May 13 [cited 2020 Dec 17] Available from.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7240870</ArticleId><ArticleId IdType="pubmed">32422057</ArticleId></ArticleIdList></Reference><Reference><Citation>Arevalo-Rodriguez I., Buitrago-Garcia D., Simancas-Racines D., Zambrano-Achig P., Campo R del, Ciapponi A. 2020 Aug. False-negative results of initial RT-PCR assays for COVID-19: a systematic Review. medRxiv. 2020.04.16.20066787.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7728293</ArticleId><ArticleId IdType="pubmed">33301459</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharfstein J.M., Becker S.J., Mello M.M. Diagnostic testing for the novel coronavirus. JAMA. 2020 Apr;323(15):1437.</Citation><ArticleIdList><ArticleId IdType="pubmed">32150622</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang A., Tong Z.-.D., Wang H.-.L., Dai Y.-.X., Li K.-.F., Liu J.-.N. Vol. 26. 2020. pp. 1337&#x2013;1339. (Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child, china. emerg infect dis). Jun.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7258461</ArticleId><ArticleId IdType="pubmed">32150527</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuehn B.M. Health workers&#x2019; antibody levels wane after SARS-CoV-2 infection. JAMA. 2021;325(2):122. Jan 12.</Citation><ArticleIdList><ArticleId IdType="pubmed">33433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021 Jan:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J., Watkeys L., Nash J., Whelan C., Davies A., Evans J. A two-phase, single cohort study of COVID-19. Antibody Sera-Surveillance. 2021:6.</Citation></Reference><Reference><Citation>Vashisht R., Patel A., Crews B.O., Garner O.B., Dahm L., Wilson C. Age- and sex-associated variations in the sensitivity of serological tests among individuals infected with SARS-CoV-2. JAMA Netw Open. 2021 Feb;4(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7881354</ArticleId><ArticleId IdType="pubmed">33576815</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A., Grant J.E., Patrick F. 2020 Oct. Cognitive deficits in people who have recovered from COVID-19 relative to controls: an N=84,285 online study. medRxiv. 2020.10.20.20215863.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Herck M.V., Delbressine J.M., Vaes A.W., Meys R., Machado F.V.C. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Research [Internet] 2020 https://openres.ersjournals.com/content/early/2020/09/01/23120541.00542-2020 Jan 1 [cited 2020 Dec 19]; Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaes A.W., Machado F.V.C., Meys R., Delbressine J.M., Goertz Y.M.J., Van Herck M. Care dependency in non-hospitalized patients with COVID-19. J Clin Med. 2020;9(9):2946. Sep.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7564703</ArticleId><ArticleId IdType="pubmed">32932582</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>